Kovai Medical Center & Hospital Ltd.
Snapshot View

1867.45 +41.20 ▲2.3%

29 March 2023, 04:01:00 PM
Volume: 624

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.kmchhospitals.com
Market Cap 2,043.41 Cr.
Enterprise Value(EV) 2,259.45 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 95.08 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 19.64 Trailing Twelve Months Ending 2022-12
Industry PE 45.91 Trailing Twelve Months Ending 2022-12
Book Value / Share 628.72 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.97 Calculated using Price: 1,867.45
Dividend Yield 0.32 Period Ending 2022-03
No. of Shares Subscribed 1.09 Cr. 10,942,262 Shares
FaceValue 10
Company Profile
Kovai Medical Center and Hospital is 500-bed multi-disciplinary super-specialty hospital located in the NH 47, opposite to Airport, Coimbatore. The hospital has more than 50 medical disciplines managed by highly qualified and trained full time medical specialists providing round the clock service. Over 1000 in patients and out patients are treated every day at the hospital.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.26%
1 Week
+1.59%
1 Month
-2.80%
3 Month
+8.04%
6 Month
+21.88%
1 Year
+15.88%
2 Year
+72.22%
5 Year
+49.31%
10 Year
+1046.38%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 25.97 32.16 25.76 29.19 22.07 19.00 24.43 16.51 18.63
Return on Capital Employed (%) 21.28 27.19 24.83 30.82 24.00 17.74 15.56 13.66 16.86
Return on Assets (%) 6.82 10.50 9.91 13.43 10.82 8.25 9.67 6.51 7.95

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 102 138 176 235 290 343 431 510 609 657
Non Curr. Liab. 186 160 162 132 212 385 572 633 570 548
Curr. Liab. 63 88 92 96 106 121 105 139 163 174
Minority Int.
Equity & Liab. 351 386 430 464 608 850 1,107 1,281 1,343 1,379
Non Curr. Assets 297 310 359 372 487 720 967 1,093 1,105 1,100
Curr. Assets 54 77 71 92 121 129 140 188 238 280
Misc. Exp. not W/O
Total Assets 351 386 430 464 608 850 1,107 1,281 1,343 1,379

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 334 402 465 531 592 628 712 690 906 974
Other Income 5 7 8 6 8 8 11 12 12 14
Total Income 339 408 473 537 600 637 722 702 918 987
Total Expenditure -261 -307 -374 -406 -464 -494 -541 -495 -646 -717
PBIDT 78 101 99 131 136 143 182 207 272 270
Interest -24 -20 -17 -15 -13 -15 -18 -33 -46 -41
Depreciation -16 -21 -21 -24 -34 -36 -52 -68 -85 -89
Taxation -14 -21 -22 -32 -31 -33 -17 -28 -36 -37
Exceptional Items
PAT 24 39 40 60 58 60 95 78 104 104
Adjusted EPS 22 35 37 55 53 55 86 71 95 95

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 62 68 97 85 99 87 126 152 186 263
Cash Fr. Inv. -8 -12 -33 -65 -32 -123 -277 -256 -180 -99
Cash Fr. Finan. -48 -52 -43 -24 -50 60 160 113 38 -120
Net Change 6 4 21 -5 17 24 9 9 44 44
Cash & Cash Eqvt 31 10 9 2 18 24 27 32 7 5

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 50.80 55.76 55.76 55.74 55.74 55.71 55.76 55.76 55.76
Public 49.20 44.24 44.24 44.26 44.26 44.29 44.24 44.24 44.24
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 28 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance of Regulation 39(3) of SEBI (LODR) Regulations 2015 for Duplicate Share Certificates Issued.
Mon, 27 Mar 2023
Closure of Trading Window
Pursuant to Clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for trading in Companys Securities shall remain closed from 1st April 2023 till the end of 48 hours after the declaration of Audited Financial Results for the Quarter/Year ended 31st March 2023 for insiders designated persons and their immediate relatives.The date of Board Meeting for declaration of Audited Financial Results of the company for the Quarter/Year ended 31st March 2023 will be intimated in due course.We request you take the above information on record.
Mon, 27 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate under Regulation 39(3) of SEBI (LODR) Regulations 2015.

Technical Scans View Details >>

Tue, 28 Mar 2023
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 6 Months High Increase in 6 Months
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,142.55 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 75,408.82 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,473.23 2,818.70 +0.5%
Cipla Ltd. 71,800.08 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,246.53 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,239.05 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,031.17 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.01 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.72 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.07 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.21 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.27 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.79 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.27 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.43 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.07 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.84 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Kovai Medical Center & Hospital Ltd.

What is Kovai Medical Center share price?

Can I buy Kovai Medical Center shares now?

What is the Dividend Yield of Kovai Medical Center?

What is the Market Cap of Kovai Medical Center?

What are the key metrics to analyse Kovai Medical Center?

What is the 52 Week High and Low of Kovai Medical Center?

What is the trend of Kovai Medical Center share price?